about
Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strainsHepatitis B virus vaccine for patients with hepatitis C virus infection.Human alveolar echinococcosis in Poland: 1990-2011Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.Four-year follow up of hepatitis C patients vaccinated against hepatitis B virusAuditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern PolandThe Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 CasesExpanding HIV-1 subtype B transmission networks among men who have sex with men in PolandMajor differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report.Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.Hypertension, dyslipidemia and cardiovascular risk in HIV infected adults in Poland.Distribution and time trends of HIV-1 variants in Poland: Characteristics of non-B clades and recombinant viruses.Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.Phylogeographic analysis on the travel-related introduction of HIV-1 non-B subtypes to Northern Poland.Time trends in HIV-1 transmitted drug resistance mutation frequency in PolandSeroprevalence of Anaplasma phagocytophilum among forestry rangers in northern and northeastern Poland.Rickettsia raoultii and Anaplasma phagocytophilum in Dermacentor reticulatus ticks collected from Bialowieza Primeval Forest European bison (Bison bonasus bonasus), Poland.Etiology of tick-borne febrile illnesses in adult residents of North-Eastern Poland: report from a prospective clinical study.Influence of HCV and HIV on development of cryoglobulinemia.Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy.Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults.The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.Changing HCV genotypes distribution in Poland--relation to source and time of infection.Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.Search for hepatitis delta virus (HDV) infection in hepatitis C patients in north-eastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B.Metabolic syndrome in HIV infected adults in Poland.Serological and molecular evidence of human granulocytic ehrlichiosis focus in the Białowieza Primeval Forest (Puszcza Białowieska), northeastern PolandPrevalence of antibodies against tick-borne encephalitis among residents of north-eastern PolandPrevalence of hepatitis B markers in patients with hepatitis C infection in north-eastern Poland: risk factors and vaccine useHighly variable year-to-year prevalence of Anaplasma phagocytophilum in Ixodes ricinus ticks in northeastern Poland: a 4-year follow-upMedical procedures and the risk of iatrogenic hepatitis C infection: case-controlled study in north-eastern Poland
P50
Q28485122-900710BA-0CD4-4025-A401-C9A3BD7C8F52Q33419707-78C98DAA-390B-40D3-BAB7-97C1B6DC2718Q33752787-51637E8D-603B-4224-8D9B-02B1E274C91FQ34119200-C903C8E5-6D35-452F-9A0E-9B12AE67F235Q34542648-B469114A-A981-4F50-A266-5EB90764D67AQ34870353-B05109A1-6DF9-499F-9AD9-BC029508125DQ35011088-2D92BBD3-E517-4C78-81A6-32850994267FQ35839025-B4102961-8211-4F14-A83F-8BBCE4F6A7DBQ35964789-9EE0C89D-6EEE-4129-B449-81E63FE0DC81Q36243929-65C30C37-3BCB-4FD9-9E65-EA81658EC091Q36289722-1B4B13B8-9D5E-4D78-8B40-A9421A4BBF98Q37418259-10D6E924-3329-43FD-BE73-F9F5A5D03F3AQ37689076-5EEEE2C5-D21B-482D-8EE7-C9104B1BE6ACQ38675771-029478EE-536D-4BF0-A168-0128D0645BDEQ38675824-30C3156A-6375-4091-918E-5C2A8D224D0AQ39338028-E2B61597-1B2B-4FB2-87D3-E7ACA2F03D6DQ39338033-FCCA2504-C897-43BA-BE84-ED404663C478Q39338042-F036350F-4020-4DBD-8C94-C3AE3547172BQ39338048-C5DC65AB-14A7-4747-A3F3-B3CC915E1F6AQ39487852-E3A6F43C-2742-44B6-9B60-83536F310652Q39834438-F82E5678-1419-4DA2-87AE-48F5A479BEC5Q40484170-6E871C58-43B6-4B60-AC90-671F2CE04947Q41460679-E07921DD-A5BA-4421-A35E-8FEEA875CFE8Q42248749-EC5F7B99-DAF1-430F-A6AE-D336C82E669EQ42251249-E657BED5-C580-4965-BA20-E47F940213C8Q42255967-508FD983-FDC6-4A24-AF27-FA375AD284DBQ42977287-60F523AA-7CE5-4761-B295-028BD25FC991Q42982110-C41BDF70-3361-4738-9063-11EC04FEBC7FQ45722294-99AFBD4A-B3CD-4870-8343-AAB16D6FF018Q49923937-1F6382BB-3C9B-4DA7-98F2-77A16164ECDCQ56776608-DEF554BB-D7C2-4976-9857-769139C68BC8Q72322043-36B9D318-AEC0-4503-9E94-A859CBC67179Q77073351-6C954CD5-7D53-40B9-A441-2E3A1A3100DCQ79370364-770CFBC8-A0D9-4C1F-AC92-AFB3C559923EQ80900098-F0CB5448-56C2-4855-8C96-E9E94B21ED14
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A Grzeszczuk
@ast
A Grzeszczuk
@en
A Grzeszczuk
@es
A Grzeszczuk
@nl
type
label
A Grzeszczuk
@ast
A Grzeszczuk
@en
A Grzeszczuk
@es
A Grzeszczuk
@nl
prefLabel
A Grzeszczuk
@ast
A Grzeszczuk
@en
A Grzeszczuk
@es
A Grzeszczuk
@nl
P106
P1153
7004106703
P31
P496
0000-0002-6420-5545